MetaReal Corporation (TYO:6182)
Japan · Delayed Price · Currency is JPY 611.00
-12.00 (-1.93%)
Aug 1, 2025, 3:30 PM JST
ShockWave Medical Income Statement
Financials in millions JPY. Fiscal year is March - February.
Millions JPY. Fiscal year is Mar - Feb.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 31, 2025 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 | Feb '21 Feb 28, 2021 | 2017 - 2021 |
| 4,075 | 4,084 | 4,177 | 4,292 | 4,159 | 4,004 | Upgrade | |
Revenue Growth (YoY) | -5.88% | -2.23% | -2.68% | 3.20% | 3.87% | 2.38% | Upgrade |
Cost of Revenue | 1,502 | 1,383 | 1,358 | 1,506 | 1,536 | 1,381 | Upgrade |
Gross Profit | 2,573 | 2,701 | 2,819 | 2,786 | 2,623 | 2,623 | Upgrade |
Selling, General & Admin | 2,494 | 2,342 | 1,950 | 2,006 | 2,135 | 2,550 | Upgrade |
Research & Development | 240.69 | 248 | 123 | 264 | 241 | - | Upgrade |
Operating Expenses | 2,711 | 2,585 | 1,998 | 2,253 | 2,531 | 2,547 | Upgrade |
Operating Income | -138.37 | 116 | 821 | 533 | 92 | 76 | Upgrade |
Interest Expense | -20.41 | -15 | -13 | -18 | -13 | -6 | Upgrade |
Interest & Investment Income | 1.95 | 1 | - | - | - | - | Upgrade |
Earnings From Equity Investments | -1.2 | -2 | -16 | -17 | -163 | - | Upgrade |
Currency Exchange Gain (Loss) | 0.58 | -1 | - | - | - | - | Upgrade |
Other Non Operating Income (Expenses) | -8.38 | 14 | 11 | 18 | 39 | -19 | Upgrade |
EBT Excluding Unusual Items | -165.83 | 113 | 803 | 516 | -45 | 51 | Upgrade |
Gain (Loss) on Sale of Investments | 284.28 | 283 | 2 | -233 | -345 | - | Upgrade |
Gain (Loss) on Sale of Assets | -20.56 | 2 | - | -5 | -8 | - | Upgrade |
Asset Writedown | -4.33 | -10 | -4 | -68 | -366 | -83 | Upgrade |
Other Unusual Items | 40.95 | 39 | 1 | -2 | -505 | - | Upgrade |
Pretax Income | 134.5 | 427 | 802 | 208 | -1,269 | -32 | Upgrade |
Income Tax Expense | -79.93 | 128 | 268 | 179 | -31 | 40 | Upgrade |
Earnings From Continuing Operations | 214.43 | 299 | 534 | 29 | -1,238 | -72 | Upgrade |
Minority Interest in Earnings | - | - | - | - | - | 4 | Upgrade |
Net Income | 214.43 | 299 | 534 | 29 | -1,238 | -68 | Upgrade |
Net Income to Common | 214.43 | 299 | 534 | 29 | -1,238 | -68 | Upgrade |
Net Income Growth | -64.85% | -44.01% | 1741.38% | - | - | - | Upgrade |
Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 11 | 11 | Upgrade |
Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 11 | 11 | Upgrade |
Shares Change (YoY) | -0.08% | 0.09% | 0.12% | 1.90% | -1.19% | 1.61% | Upgrade |
EPS (Basic) | 19.72 | 27.58 | 49.78 | 2.71 | -116.17 | -6.46 | Upgrade |
EPS (Diluted) | 19.70 | 27.48 | 49.13 | 2.71 | -116.17 | -6.46 | Upgrade |
EPS Growth | -64.83% | -44.07% | 1709.99% | - | - | - | Upgrade |
Free Cash Flow | - | -148 | 924 | 502 | 520 | 869 | Upgrade |
Free Cash Flow Per Share | - | -13.60 | 84.99 | 46.23 | 48.79 | 80.57 | Upgrade |
Dividend Per Share | - | - | - | - | - | 6.000 | Upgrade |
Gross Margin | 63.15% | 66.14% | 67.49% | 64.91% | 63.07% | 65.51% | Upgrade |
Operating Margin | -3.40% | 2.84% | 19.66% | 12.42% | 2.21% | 1.90% | Upgrade |
Profit Margin | 5.26% | 7.32% | 12.78% | 0.68% | -29.77% | -1.70% | Upgrade |
Free Cash Flow Margin | - | -3.62% | 22.12% | 11.70% | 12.50% | 21.70% | Upgrade |
EBITDA | 107.83 | 385 | 1,183 | 1,015 | 693 | 682 | Upgrade |
EBITDA Margin | 2.65% | 9.43% | 28.32% | 23.65% | 16.66% | 17.03% | Upgrade |
D&A For EBITDA | 246.19 | 269 | 362 | 482 | 601 | 606 | Upgrade |
EBIT | -138.37 | 116 | 821 | 533 | 92 | 76 | Upgrade |
EBIT Margin | -3.40% | 2.84% | 19.66% | 12.42% | 2.21% | 1.90% | Upgrade |
Effective Tax Rate | - | 29.98% | 33.42% | 86.06% | - | - | Upgrade |
Advertising Expenses | - | 228 | 141 | 210 | 187 | 224 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.